Acetylsalicylic acid Completed Phase 3 Trials for Vascular Risk / Atrial Fibrillation (AF) Prevention

CompletedPrevention3 IdentifierTitleDrugs
NCT00249873Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)
NCT00244426S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation
NCT00496769A Phase III Study of Apixaban in Patients With Atrial Fibrillation